This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • Bendamustine, Gemcitabine and Vinorelbine (BeGEV) ...
Clinical trial

Bendamustine, Gemcitabine and Vinorelbine (BeGEV) as Induction Therapy in Relapsed/Refractory Hodgkin's Lymphoma Patients

Read time: 1 mins
Last updated:27th May 2013
Test of bendamustine in combination with gemcitabine and vinorelbine could contribute to a higher response rate with the reduction of toxic side effects
Category Value
Study start date 2013-05-27

View full details